Exogenous IGFBP-2 promotes proliferation, invasion and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway

Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma

(2014) S Han et al.   BRITISH JOURNAL OF CANCER

The Size of Blood–Brain Barrier Opening Induced by Focused Ultrasound is Dictated by the Acoustic Pressure

(2014) Hong Chen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Plasma IGFBP-2 Levels after Postoperative Combined Radiotherapy and Chemotherapy Predict Prognosis in Elderly Glioblastoma Patients

(2014) Sheng Han et al.   PLoS One

Interleukin-1β promotes hypoxia-induced apoptosis of glioblastoma cells by inhibiting hypoxia-inducible factor-1 mediated adrenomedullin production

(2014) W Sun et al.   Cell Death & Disease

Integrin α3 is overexpressed in glioma stem-like cells and promotes invasion

(2013) M Nakada et al.   BRITISH JOURNAL OF CANCER

Notice of Retraction

(2013)   CARCINOGENESIS

Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) Promotes Growth and Survival of Breast Epithelial Cells: Novel Regulation of the Estrogen Receptor

(2013) Emily J. Foulstone et al.   ENDOCRINOLOGY

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

(2013) W. Wick et al.   NEUROLOGY

Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin

(2013) S Kale et al.   ONCOGENE

PMA and Ionomycin Induce Glioblastoma Cell Death: Activation-Induced Cell-Death-Like Phenomena Occur in Glioma Cells

(2013) Sheng Han et al.   PLoS One

Phosphorylated SATB1 is associated with the progression and prognosis of glioma

(2013) S Han et al.   Cell Death & Disease

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group

(2012) Wei Yan et al.   NEURO-ONCOLOGY

Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF- B network

(2012) K. M. Holmes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3

(2012) Yi Wan et al.   Chinese Journal of Cancer

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

(2011) C C Uzoh et al.   BRITISH JOURNAL OF CANCER

The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton

(2011) Masanobu Kawai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production

(2011) Claudia R. Oliva et al.   PLoS One

Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells

(2010) Yuehan Wu et al.   BREAST CANCER RESEARCH AND TREATMENT

Blood-brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edema

(2009) Nicola Marchi et al.   EPILEPSIA

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas

(2009) Yi Lin et al.   NEURO-ONCOLOGY

Defined Carboxy-Terminal Fragments of Insulin-Like Growth Factor (IGF) Binding Protein-2 Exert Similar Mitogenic Activity on Cultured Rat Growth Plate Chondrocytes as IGF-I

(2008) Daniela Kiepe et al.   ENDOCRINOLOGY